Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Lichen planus pigmentosus may indicate undetected hepatitis C infection.

GLPLS and LPP are variants of lichen planus.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The patient has frontal fibrosing alopecia (FFA).

New understanding and treatments for hair loss are improving, but more research is needed.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

Treat active lichen planopilaris early to prevent permanent hair loss.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The study found that steroids and tetracycline helped treat active Lichen planopilaris, and hair transplants were good for later stages.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.